News
Glaucoma is one of the world’s leading causes of irreversible blindness, and currently, no therapies exist to directly protect retinal ganglion cells (RGC) from degradation and loss. NIH inventors have developed a method to treat glaucoma using exosomes derived from bone marrow-derived mesenchymal
The NIH is a leader in medical breakthroughs, with the discovery of new biological molecules, processes and pathways, novel medical technologies, and innovative applications of existing medical knowledge. Many important medical breakthroughs begin in research laboratories at the NIH, and Technology
National Cancer Institute (NCI) Technology Transfer Center (TTC) Technology Transfer and Patent Specialist The TTC is seeking an exceptional, dynamic candidate for the position of Technology Transfer and Patent Specialist with responsibility for advising on and performing the full range of
The Technology Transfer and Intellectual Property Office (TTIPO) at the National Institute of Allergy and Infectious Diseases (NIAID) at the National Institutes of Health (NIH) is seeking qualified candidates for its Technology Transfer and Patent Specialist position. This position will be